TotalEnergies commits to sustainable aviation fuel production ahead of EU mandates

Patrick Pouyanné Chairman and Chief Executive Officer TotalEnergies SE
Patrick Pouyanné Chairman and Chief Executive Officer - TotalEnergies SE
0Comments

TotalEnergies is advancing its efforts to decarbonize air transportation by producing and distributing sustainable aviation fuel (SAF). By 2028, the company aims to produce over half a million tons of SAF annually, exceeding the European blending mandate of 6% set for 2030.

Patrick Pouyanné, Chairman and CEO of TotalEnergies, stated, “TotalEnergies is taking action to meet the strong demand from the aviation industry to reduce its carbon footprint. Sustainable aviation fuels are essential to bring the air industry’s CO2 emissions down immediately. Their development is fully aligned with our approach to get to net zero, together with society.”

The Grandpuits biorefinery will be transformed into a zero-crude platform with a production capacity of 230,000 tons per year by 2026. TotalEnergies has partnered with SARIA for feedstock supply. The La Mède biorefinery will produce 15,000 tons of SAF this year for distribution in southern France. In Normandy and Antwerp refineries, coprocessing projects are underway or planned for increased SAF production.

TotalEnergies supplies SAF-blended aviation fuel to several French airports and has signed significant contracts with airlines like Air France-KLM and Volotea. These agreements aim to reduce flight emissions through long-term SAF purchases.

In collaboration with aerospace groups such as Airbus and Safran, TotalEnergies is researching the impact of SAF on aircraft performance. The company’s Solaize research center focuses on overcoming challenges related to feedstock for increasing SAF production.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.